BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen S, Peng Z, Zhang Y, Chen M, Li J, Guo R, Li J, Li B, Mei J, Feng S, Kuang M. Lack of Response to Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Abandon or Repeat? Radiology 2021;298:680-92. [PMID: 33464183 DOI: 10.1148/radiol.2021202289] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Cao Y, Sun T, Guo X, Ouyang T, Kan X, Chen L, Liang B, Wang M, Zheng C. Sorafenib Versus Apatinib Both Combined Transarterial Chemoembolization for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: A Comparative Retrospective Study. Front Oncol 2021;11:673378. [PMID: 34414104 DOI: 10.3389/fonc.2021.673378] [Reference Citation Analysis]
2 Georgiades C. If at First You Don't Succeed, TACE and TACE Again. Radiology 2021;298:693-4. [PMID: 33475470 DOI: 10.1148/radiol.2021204248] [Reference Citation Analysis]